Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes

Diabetes

Volumn 48, Issue 3, 1999, Pages 570-576

  Lewis, Gary F ^a,b   Carpentier, André ^a   Vranic, Mladen ^a   Giacca, Adria ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCONEOGENESIS; HORMONAL REGULATION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIVER METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0032972425     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.3.570     Document Type: Article

References (46)

1. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH: Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55:1278-1283, 1975
2. Eaton KP, Allen RC, Schade DS: Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. J Clin Endocrinol Metab 56:1294-1300, 1983
3. Ader M, Bergman RN: Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 258:E1020-E1032, 1990
4. Lewis GF, Giacca A, Vranic M, Steiner G: Direct and indirect effects of insulin on hepatic glucose and very low density lipoprotein (VLDL) production. Curr Opin Endocrinol Diab 5:235-245, 1998
5. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A: Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45:454-462, 1996
6. Lewis GF, Vranic M, Giacca A Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am J Physiol 272:E371-E378, 1997
7. Sindelar DK, Balcom JH, Chu CA, Neal DW, Cherrington AD: A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes 45:1594-1604, 1996
8. Bergman RN: New concepts in extracellular signaling for insulin action: the single gateway hypothesis. Rec Progr Horm Res 52:359-387, 1997
9. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
10. Rebrin K, Steil GM, Mittelman SD, Bergman RN: Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749, 1996
11. Lewis CK, Vranic M, Harley P, Giacca A: Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 46:1111-1119, 1997
12. Lewis GF, Vranic M, Giacca A: Role of free fatty acids and glucagon in the extrahepatic effect of insulin on glucose production in humans. Am J Physiol 275:E177-E186, 1998
13. Sindelar DK, Chu C, Rohlie M, Neal DW, Swift LL, Cherrington AD: The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46:187-196, 1997
14. Giacca A, Fisher SJ, McCall RH, Shi ZQ, Vranic M: Direct and indirect effects of insulin in suppressing glucose production in depancreatised dogs: role of glucagon. Endocrinology 138:999-1007, 1997
15. Mittelman S, Fu YY, Rebrin K, Steil G, Bergman RN: Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest 100:3121-3130, 1997
16. Shishko PI, Kovalev PA, Goncharov VG, Zajarny IU: Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes 41:1042-1049, 1992
17. Garvey WT, Olefsky JM, Marshall S: Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes. J Clin Invest 76:22-30, 1985
18. Marshall S Olefsky JM: Effects of insulin incubation on insulin binding, glucose transport, and insulin degradation by isolated rat adipocytes. Evidence for hormone-induced desensitization at the receptor and postreceptor level. J Clin Invest 66:763-772, 1980
19. Wardzala LJ, Hirshman M, Pofcher E, Horton ED, Mead PM, Cushman SW, Horton ES: Regulation of glucose utilization in adipose cells and muscle after long-term experimental hyperinsulinemia in rats. J Clin Invest 76:460-469, 1985
20. Radziuk J, Barron P, Najm H, Davies J: The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs. J Clin Invest 92:1713-1721, 1993
21. Rizza RA, Mandarino LJ, Genest J, Baker BA, Gerich JE: Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 28:70-75, 1985
22. Marangou AG, Weber KM, Boston RC, Aitken PM, Heggie JC, Kirsner RL, Best JD, Alford FP: Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes 35:1383-1389, 1986
23. Consoli A: Role of liver in pathophysiology of NIDDM (Review). Diabetes Care 15:430-441, 1992
24. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini, E, DeFronzo RA: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205-213, 1989
25. McCall RH, Wiesenthal SR, Shi ZQ, Polonsky K, Giacca A: Insulin acutely suppresses glucose production by both peripheral and hepatic effects in normal dogs. Am J Physiol 37:E346-E356, 1998
26. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HL, Vranic M: Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90:1769-1777, 1992
27. Gupta N, Sandhu H, Goh T, Weisenthal S, Tchipashvili V, Lam L, Giacca A: Euglycemia acutely restores the direct hepatic effect of insulin on glucose production in depancreatise dogs (Abstract). Diabetes 44 (Suppl. 1):A41, 1998
28. 3H]glucose. Am J Physiol 258:E228-E233, 1990
29. Lewis GF, Steiner G, Polonsky KS, Weller B, Zinman B: A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion. J Clin Endocrinol Metab 79:66-70, 1994
30. Garner CW: Boronic acid inhibitors of porcine pancreatic lipase. J Biol Chem 255:5064-5068, 1980
31. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
32. Finegood DT, Bergman RN, Vranic M: Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37:1025-1034, 1988
33. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
34. Finegood DT, Bergman RN: Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am J Physiol 244:E472-E479, 1983
35. Bradley DC, Steil GM, Bergman RN: Quantitation of measurement error with optimal segments: basis for adaptive time course smoothing. Am J Physiol 264:E902-E911, 1993
36. De Feo P, Perriello G, De Cosmo S, Ventura MM, Campbell PJ, Brunetti, P, Gerich JE, Bolli GB: Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 35:563-569, 1986
37. Campra JL, Reynolds TB: The hepatic circulation. In The Liver. Biology and Pathobiology. Arias IM, Popper H, Schachter D, Shafritz DA, Eds. New York, Raven Press, 1982, p. 627-645
38. Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuya H, Blix P, Horwitz DL, Rubenstein AH: Characterization of seven C-peptide antisera. Diabetes 27 (Suppl. 1):170-177, 1978
39. Hartling SG, Dinesen B, Kappelgard AM, Faber OK, Binder C: ELISA for human proinsulin. Clin Chim Acta 156:289-297, 1986
40. Sindelar DK, Chu CA, Neal DW, Cherrington AD: Interaction of equal increments in arterial and portal vein insulin on hepatic glucose production in the dog. Am J Physiol 273:E972-E980, 1997
41. Baron AD, Schaeffer L, Shragg P, Koltennan OG: Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetes. Diabetes 36:274-283, 1987
42. Prager R, Wallace P, Olefsky JM: Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 36:607-611, 1987
43. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo, RA: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72:96-107, 1991
44. Shi ZQ, Wasserman D, Vranic M: Metabolic implications of exercise and physical fitness in physiology and diabetes. In Ellenberg and Rifkin Diabetes Mellitus. Porte D, Sherwin R, Eds. Norwalk, CT, Appleton and Lange, 1997, p. 653-687
45. Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH: Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience (Review). Diabetes Care 15:666-692, 1992
46. Fisher SJ, Shi ZQ, Lickley HLA, Efendic S, Vranic M, Giacca A: A moderate decline in specific activity does not lead to an underestimation of hepatic glucose production during a glucose clamp. Metabolism 45:587-593, 1996.